Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Dilutive Outstanding of Anti-dilutive Effect (Details)

v3.8.0.1
Net Loss Per Share - Schedule of Dilutive Outstanding of Anti-dilutive Effect (Details) - shares
9 Months Ended
Apr. 30, 2018
Apr. 30, 2017
Total 18,858,629 14,341,051
Stock Options [Member]    
Total 8,488,570 3,731,311
Restricted Stock Units [Member]    
Total 1,412,000 1,115,000
Warrants [Member]    
Total 8,958,059 9,494,740